Evidence map›Paper›PMID 32125460›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

5-HT

Toshikatsu Okumura, Tsukasa Nozu, Masatomo Ishioh, Sho Igarashi, Shima Kumei, Masumi Ohhira

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Toshikatsu OkumuraDepartment of Medicine, Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan. okumurat@asahikawa-med.ac.jp.ORCID http://orcid.org/0000-0003-1810-007X
Tsukasa NozuDepartment of Regional Medicine and Education, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Masatomo IshiohDepartment of Medicine, Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Sho IgarashiDepartment of Medicine, Division of Gastroenterology and Hematology/Oncology, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Shima KumeiDepartment of General Medicine, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Masumi OhhiraDepartment of General Medicine, Asahikawa Medical University, Midorigaoka Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Asahikawa Medical University · JPAsahikawa Medical College Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have recently demonstrated that levodopa acts centrally to induce antinociceptive action against colonic distension through dopamine D

Indexed as

AnalgesicsAnimalsBehavior, AnimalBrainColonDisease Models, AnimalHumansLevodopaNociceptionNociceptive PainPain ThresholdRats, Sprague-DawleyReceptors, CannabinoidReceptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor AgonistsAnalgesicsLevodopaReceptors, CannabinoidReceptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor Agonists5-HT2AAntinociceptionCentral nervous systemColonic distensionLevodopa

Identifiers

PMID32125460
OpenAlexW3009918653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.